Frederic Moulin

596 total citations
13 papers, 362 citations indexed

About

Frederic Moulin is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Frederic Moulin has authored 13 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Frederic Moulin's work include Drug-Induced Hepatotoxicity and Protection (5 papers), Cannabis and Cannabinoid Research (3 papers) and Diet, Metabolism, and Disease (3 papers). Frederic Moulin is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (5 papers), Cannabis and Cannabinoid Research (3 papers) and Diet, Metabolism, and Disease (3 papers). Frederic Moulin collaborates with scholars based in United States, Belgium and Germany. Frederic Moulin's co-authors include Donna M. Dambach, Bárbara A. Andrews, Robert A. Roth, Patricia E. Ganey, Bryan L. Copple, Umesh Hanumegowda, Gregory J. Opiteck, Jun-Hsiang Lin, Stanley A. Hefta and Ji Gao and has published in prestigious journals such as Blood, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Frederic Moulin

12 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederic Moulin United States 8 133 94 61 49 49 13 362
Xiaomin Deng China 11 232 1.7× 100 1.1× 59 1.0× 27 0.6× 66 1.3× 20 450
Charles E. Ruegg United States 9 177 1.3× 155 1.6× 67 1.1× 34 0.7× 29 0.6× 12 469
Sophie Regan United Kingdom 10 288 2.2× 160 1.7× 124 2.0× 45 0.9× 31 0.6× 14 615
Carlo Sensenhauser United States 11 140 1.1× 126 1.3× 24 0.4× 41 0.8× 17 0.3× 12 352
Cerys Lovatt United Kingdom 6 116 0.9× 148 1.6× 44 0.7× 24 0.5× 15 0.3× 6 298
Jennie Walgren United States 9 186 1.4× 301 3.2× 28 0.5× 62 1.3× 85 1.7× 14 593
Daniel C. Kemp United States 9 133 1.0× 179 1.9× 31 0.5× 20 0.4× 43 0.9× 11 488
Kaori Nakamoto United States 5 160 1.2× 122 1.3× 55 0.9× 17 0.3× 10 0.2× 5 359
Noriko Masubuchi Japan 13 142 1.1× 161 1.7× 27 0.4× 35 0.7× 38 0.8× 17 450
Simon Bucher France 13 98 0.7× 138 1.5× 59 1.0× 21 0.4× 21 0.4× 19 407

Countries citing papers authored by Frederic Moulin

Since Specialization
Citations

This map shows the geographic impact of Frederic Moulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Moulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Moulin more than expected).

Fields of papers citing papers by Frederic Moulin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederic Moulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Moulin. The network helps show where Frederic Moulin may publish in the future.

Co-authorship network of co-authors of Frederic Moulin

This figure shows the co-authorship network connecting the top 25 collaborators of Frederic Moulin. A scholar is included among the top collaborators of Frederic Moulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederic Moulin. Frederic Moulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Li, Yuxi, Qiangen Wu, Montserrat Puig, et al.. (2025). 7-Hydroxycannabidiol and 7-carboxycannabidiol induced cytotoxicity via apoptosis and endoplasmic reticulum stress in human hepatic cells. Archives of Toxicology. 99(6). 2627–2638.
2.
Chen, Si, Xilin Li, Qiangen Wu, et al.. (2024). Investigation of cannabidiol-induced cytotoxicity in human hepatic cells. Toxicology. 506. 153884–153884. 6 indexed citations
3.
Chen, Si, Yuxi Li, Qiangen Wu, et al.. (2024). Metabolism and liver toxicity of cannabidiol. PubMed. 42(3). 238–254. 12 indexed citations
4.
Atienzar, Franck A., Eric A.G. Blomme, Minjun Chen, et al.. (2016). Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. BioMed Research International. 2016. 1–20. 44 indexed citations
5.
Gao, Min, Donald R. O’Boyle, Julie A. Lemm, et al.. (2013). 1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO. Journal of Hepatology. 58. S573–S574. 3 indexed citations
6.
Flint, Oliver, Jae Kwagh, Faye Wang, et al.. (2009). Tanespimycin Prevents Bortezomib Toxicity and Preserves Neuronal Morphology in Primary Rat Dorsal Root Ganglion Cultures.. Blood. 114(22). 2847–2847. 1 indexed citations
7.
Dambach, Donna M., Bárbara A. Andrews, & Frederic Moulin. (2005). New Technologies and Screening Strategies for Hepatotoxicity: Use of In Vitro Models. Toxicologic Pathology. 33(1). 17–26. 128 indexed citations
8.
Gao, Ji, Stanley A. Hefta, Gregory J. Opiteck, et al.. (2004). Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. Toxicology in Vitro. 18(4). 533–541. 37 indexed citations
9.
Copple, Bryan L., Frederic Moulin, Umesh Hanumegowda, Patricia E. Ganey, & Robert A. Roth. (2003). Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers. Journal of Pharmacology and Experimental Therapeutics. 305(2). 417–425. 39 indexed citations
10.
Moulin, Frederic. (2002). Predicted Regional Flux of Hydrogen Sulfide Correlates with Distribution of Nasal Olfactory Lesions in Rats. Toxicological Sciences. 66(1). 7–15. 31 indexed citations
11.
Moulin, Frederic, Bryan L. Copple, Patricia E. Ganey, & Robert A. Roth. (2001). Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure. American Journal of Physiology-Gastrointestinal and Liver Physiology. 281(6). G1423–G1431. 29 indexed citations
12.
Moulin, Frederic, Julia M. Pearson, A. Eric Schultze, et al.. (1996). Thrombin Is a Distal Mediator of Lipopolysaccharide-Induced Liver Injury in the Rat. Journal of Surgical Research. 65(2). 149–158. 26 indexed citations
13.
Bailie, Marc B., Paul A. Jean, Patrick B. Lappin, et al.. (1995). Vitamin A or Zymosan Pretreatment Attenuates α-Naphthylisothiocyanate-Induced Liver Injury. Toxicology and Applied Pharmacology. 134(1). 63–70. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026